Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.
Frank TackeKlaus H W BoekerHartwig KlinkerRenate HeynePeter BuggischAnita PathilJohannes WiegandMarkus CornbergChristian LangeFlorian van BoemmelStefan ZeuzemStefan MaussPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
German Clinical Trials Register (DRKS; ID DRKS00009717).